ArticleJournal of cancer & allied specialties2024
Clinical Outcome of Patients Receiving Rituximab in Combination with Bendamustine in Indolent B-cell Lymphomas: A Single-center Institutional Study.
Zurrya Fasih Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.